FDA Approves OncoSil Device for Unresectable Distal Cholangiocarcinoma

The FDA has approved the OncoSil Device, making it the first FDA-approved Class III medical device specifically indicated for unresectable distal cholangiocarcinoma (dCCA). This provides a new therapeutic option for patients with this rare and aggressive malignancy, which is often diagnosed at an advanced stage when surgical removal is not possible.